(Q39940651)

English

Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study

scientific article published on November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

Saumier D

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Duong A

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Haine D

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Garceau D

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sampalis J

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

The Journal of Nutrition, Health and Aging

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

808-812

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

https://scigraph.springernature.com/pub.10.1007/s12603-009-0217-4

0 references

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0217-4

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0217-4

21 January 2018

Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET imaging of amyloid deposition in patients with mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between frontal gray matter volume and cognition varies across the healthy adult lifespan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

“Mini-mental state”

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memory function in normal aging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's Disease Assessment Scale (ADAS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://pubmed.ncbi.nlm.nih.gov/19812871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12603-009-0217-4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39940651&oldid=1879130567"